Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group
der Sluis, Inge M., Groot‐Kruseman, Hester, te Loo, Maroeska, Tissing, Wim J.E., den Bos, Cor, Kaspers, Gertjan J.L., Bierings, Marc, Kollen, Wouter J.W., König, Thorsten, Pichlmeier, Uwe, Kühnel, Hans‐Jürgen, Pieters, Rob
Published in Pediatric blood & cancer (01.08.2018)
Published in Pediatric blood & cancer (01.08.2018)
Get full text
Journal Article
Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia
van der Sluis, Inge, Möricke, Anja, Escherich, Gabriele, von Stackelberg, Arend, Holter, Wolfgang, Klingebiel, Thomas, Flotho, Christian, Legien, Sabine, Tissing, Wim, Bierings, Marc, Guimbal-Schmolck, Cecile, Pichlmeier, Uwe, Kühnel, Hans-Jürgen, Pieters, Rob
Published in Haematologica (Roma) (01.11.2013)
Published in Haematologica (Roma) (01.11.2013)
Get full text
Journal Article
Anti–Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials
Willer, Andrea, Gerß, Joachim, König, Thorsten, Franke, Dieter, Kühnel, Hans-Jürgen, Henze, Günter, von Stackelberg, Arendt, Möricke, Anja, Schrappe, Martin, Boos, Joachim, Lanvers-Kaminsky, Claudia
Published in Blood (24.11.2011)
Published in Blood (24.11.2011)
Get full text
Journal Article